Abstract
In a feasibility study using a prototype, lateral-flow test for human papillomavirus type 16, 18, and/or 45 (HPV16/18/45) E6 oncoproteins, 51 of 75 (68%; 95% confidence interval [95% CI] of 56 to 78%) of HPV16/18/45 DNA-positive specimens from women with a diagnosis of CIN3+ (cervical intraepithelial neoplasia grade 3+ or cervical cancer) tested positive for HPV16/18/45 E6 oncoprotein. None of 16 (95% CI of 0 to 37%) HPV16/18/45 DNA-positive cervical specimens from women with a negative or CIN1 diagnosis tested positive for HPV16/18/45 E6 oncoprotein.
Original language | English (US) |
---|---|
Pages (from-to) | 4646-4648 |
Number of pages | 3 |
Journal | Journal of clinical microbiology |
Volume | 48 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2010 |
Externally published | Yes |
ASJC Scopus subject areas
- Microbiology (medical)